Aclasta medicine 5mg/100ml Zoledronic acid treatment of osteoporosis

Aclasta drug infusion solution 5mg/100 ml indicated for postmenopausal osteoporosis, osteoporosis in men, prevention of clinical fractures after hip fractures in men & women, corticosteroid osteoporosis.

Aclasta medicine 5mg/100ml Zoledronic acid treatment of osteoporosis

  • Active ingredient: A 100ml bottle of solution contains 5mg of Zoledronic acid (anhydrous), which corresponds to 5,330mg of zoledronic acid monohydrate.
  • Excipients: Mannitol, sodium citrate, water for injection.
  • Dosage form: Infusion solution. Aseptic solution, transparent and colorless.
  • Manufacturer: Novartis
  • Aclasta Drug Prices: COMMENT below for prices OR Click on the link: https://thuoclp.com/chatFB type “Aclasta”